Deepti Loharikar is a healthcare policy strategist and trained attorney with Venable LLP who advises national stakeholders and guides clients on federal regulatory strategy, agency engagement, and emerging health policy trends. She brings a cross-HHS perspective shaped by her work at HRSA, where she led Affordable Care Act implementation for rural communities, and at CMS, where she developed oversight strategies for the CO-OP Program.
Before joining Venable, Deepti held senior roles at national healthcare associations, directing federal regulatory strategy for a behavioral health organization, where she founded and chaired its Policy Council. She also served as director of federal and state public policy for a national trade association, guiding advocacy initiatives and shaping policy across pharmacy, privacy, and healthcare access. Drawing on experience as a healthcare attorney, federal official, and association leader, Deepti provides strategic guidance to help clients navigate regulatory change and advance policy objectives.
Daniel Fellenbaum is a Senior Director at Penta, where he advises clients at the intersection of policy, business, and stakeholder strategy, including strategic communications. An attorney specializing in healthcare policy, he focuses on Medicare Advantage, pharmaceutical policy, and emerging AI innovation in healthcare. He counsels clients on federal policy, congressional dynamics, and the evolving payer landscape, drawing on experience at organizations including UnitedHealth Group, Cencora, and PhRMA. His work helps shape strategies that improve patient access, affordability, and health outcomes.
He began his career advising a Member of Congress and representing companies on government affairs and policy issues. He holds a J.D. from Cleveland State University College of Law and a B.A. from The Ohio State University.